In 2023, the import value of opacifying preparations, X-Ray, diagnostic reagents to China stood at 259.86 million USD. Over the last two years, the import value demonstrated a positive trend, with a year-on-year variation of 4.08% in 2023 following a minor decline of -0.63% in 2022. Tracking the performance over the last five years, the average compound annual growth rate (CAGR) was 4.8%, suggesting moderate growth in this duration.
Looking ahead, forecasted data up to 2028 indicate a steady increase in import values, with a forecasted 5-year CAGR of 2.62%. Key future trends to monitor include advancements in medical imaging technologies and the increasing demand driven by China's expanding healthcare infrastructure. Moreover, any changes in international trade policies and domestic production capabilities could also significantly impact the import trends of these diagnostic reagents.
